期刊
JOURNAL OF CONTROLLED RELEASE
卷 362, 期 -, 页码 44-57出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2023.08.026
关键词
Tumor-associated fibroblasts; Tryptase; Molecular imprinting; Tumor immunogenic death; Tumor therapy
This study developed a novel nanoparticle to regulate tumor-associated fibroblasts and improve the efficacy of tumor immunotherapy. It was found that inhibiting tryptase secreted by mast cells can reduce the activation of tumor-associated fibroblasts and enhance the immunogenic cell death effect. Furthermore, this nanoparticle can remodel the immunosuppressive microenvironment.
Insufficient tumor accumulation and distribution of immunogenic cell death (ICD) inducer as well as low antitumor immunity severely restrict the therapeutic efficacy of tumor immunotherapy. Tumor associated fibroblasts (TAFs) are important in tumor extracellular matrix (ECM) remodeling and immune evasion. Reprogramming tumor immunosuppressive microenvironment via TAFs regulation might present a promising way for enhanced ICD effect and complete tumor elimination. In this study, TAFs derived tryptase imprinted nanoparticles (DMSN@MIPs) are developed to modulate TAFs and improve tumor immunotherapy effect of doxorubicin liposomes (DOX/LIP). Tryptase (TPS), secreted by mast cells, are found to support tumor growth via transcriptionally activating TAFs to an activated state with increased expression of fibroblast activation marker alpha-smooth muscle actin (alpha-SMA). DMSN@MIPs canbe used as artificial antibodies, which effectively neutralize TPS, reduce TAFs activation, promote intra-tumor penetration of DOX/LIP and enhance ICD effect induced by DOX/LIP. In addition, the combined administration system remodels immunosuppressive microenvironment, which not only significantly up-regulates immune cells (DC cells, CD8+T cells, NK cells), but also significantly down-regulates immunosuppressive cells (Treg cells, MDSCs cells). Our results support the DMSN@MIPs canbe a promising approach to improve ICD efficacy in cancer immunotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据